⌘K
Loading ticker…
Stereotaxis, Inc. Common Stock · Healthcare · Medical Equipment
38 is not yet a leadership-grade RS read, Market Stance is 50
As of 2026-06-11, Stereotaxis, Inc. Common Stock (STXS) has a 3-month relative strength percentile of 38 within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 50 (Neutral). Sector: Healthcare. Average daily range 5.5%, relative volume 0.51×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
STXS is in a stage 4 downtrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -4.4% / -22.7%.
STXS is held by 4 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $4M notional. Top 3 carry $8M.
Top 4 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $4M |
| IWMiShares Russell 2000 ETF | 0.00% | $3M |
| VXFVanguard Extended Market ETF | 0.00% | $2M |
| IWOiShares Russell 2000 Growth ETF | 0.01% | $837K |